News
-
News Post
Dr. Nisha Thampi, medical director for CHEO’s infection prevention and control program, talked to the Globe and Mail about CHEO seeing more hospital admissions for RSV as we enter the 2025-26 peak viral season.
News PostCarly Demczyk cares for critically ill children in the Pediatric Intensive Care Unit (PICU) at CHEO, and as a pediatric nurse, she sees families in their most difficult moments.
The experiences sit with her, and she takes time to reflect after each shift.
News PostFor immediate release: Oct. 1, 2025
Ottawa – Ottawa Public Health (OPH), CHEO, and local birthing hospitals – including The Ottawa Hospital, Hôpital Montfort, and Queensway Carleton Hospital – are urging parents to immunize eligible infants and high-risk children against respiratory syncytial virus (RSV) this fall.
News PostFamilies of kids with cancer will get faster and more convenient access to essential bloodwork closer to home thanks to a partnership of CHEO and the Eastern Ontario Regional Laboratory Association (EORLA).
As of Sept.
News PostWhen Kassy was a toddler, her mother Nicole Cummins noticed something different.
“She was always hungry,” Cummins recalled.
News PostCamryn’s migraines were getting more painful and persistent. Then there was a constant whooshing sound in her ear.
News PostNews PostNews PostPhysiotherapists at CHEO have created a bilingual video series as part of an education campaign that encourages children and youth to move while receiving chemotherapy to avoid long-term complications.
This groundbreaking eight-part video series — By CHEO - May 30, 2025
News PostThanks to a rapid, coordinated response, seven in 10 babies born at eastern Ontario hospitals received protection from respiratory syncytial virus, or RSV, during the first season of Ontario’s new immunization program — a major step forward in safeguarding infant health.
This feat was accomplished thanks to leadership from CHEO and Kids Come First, which mobilized rapidly once Ontario launched its publicly funded protection program for RSV in November 2024.
This website uses cookies to enhance usability and provide you with a more personal experience. By using this website, you agree to our use of cookies as explained in our Privacy Policy.